DRDO s 2-DG was Found to be Safe in COVID-19 Patients: Govt
The patients treated with 2-DG showed faster symptomatic cure than Standard of Care (SoC) on various endpoints
| 18 May 2021 8:07 AM GMT
New Delhi: Defence Minister Rajnath Singh and Health Minister Dr Harsh Vardhan on Monday released the first batch of the developed anti- COVID-19 drug, 2-deoxy-D-glucose (2-DG). Drugs Controller General of India (DCGI), the national drug regulator, had cleared the formulation on May 1 for emergency use as an adjunct therapy in moderate to severe COVID-19 patients.
The Ministry of Defence had said in a release earlier this month that 2-DG has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), New Delhi, a lab of the Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy s Laboratories.
Explained: How Does 2-DG, DRDO s New Oral Covid Drug Work?
outlookindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outlookindia.com Daily Mail and Mail on Sunday newspapers.
A masterly academic response : Twitter stunned as Health Minister rebuts Lancet editorial by sharing blog post
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.